408 related articles for article (PubMed ID: 25417101)
1. Camouflage and misdirection: the full-on assault of ebola virus disease.
Misasi J; Sullivan NJ
Cell; 2014 Oct; 159(3):477-86. PubMed ID: 25417101
[TBL] [Abstract][Full Text] [Related]
2. Immune evasion in ebolavirus infections.
Audet J; Kobinger GP
Viral Immunol; 2015 Feb; 28(1):10-8. PubMed ID: 25396298
[TBL] [Abstract][Full Text] [Related]
3.
Woolsey C; Borisevich V; Agans KN; Fenton KA; Cross RW; Geisbert TW
mBio; 2021 Aug; 12(4):e0151721. PubMed ID: 34372693
[TBL] [Abstract][Full Text] [Related]
4. Immunological features underlying viral hemorrhagic fevers.
Messaoudi I; Basler CF
Curr Opin Immunol; 2015 Oct; 36():38-46. PubMed ID: 26163194
[TBL] [Abstract][Full Text] [Related]
5. The roles of ebolavirus glycoproteins in viral pathogenesis.
Ning YJ; Deng F; Hu Z; Wang H
Virol Sin; 2017 Feb; 32(1):3-15. PubMed ID: 27853993
[TBL] [Abstract][Full Text] [Related]
6. Filoviral immune evasion mechanisms.
Ramanan P; Shabman RS; Brown CS; Amarasinghe GK; Basler CF; Leung DW
Viruses; 2011 Sep; 3(9):1634-49. PubMed ID: 21994800
[TBL] [Abstract][Full Text] [Related]
7. Characterization of host immune responses in Ebola virus infections.
Wong G; Kobinger GP; Qiu X
Expert Rev Clin Immunol; 2014 Jun; 10(6):781-90. PubMed ID: 24742338
[TBL] [Abstract][Full Text] [Related]
8. Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses.
Wrensch F; Karsten CB; Gnirß K; Hoffmann M; Lu K; Takada A; Winkler M; Simmons G; Pöhlmann S
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S210-8. PubMed ID: 26034199
[TBL] [Abstract][Full Text] [Related]
9. Human Ebola virus infection results in substantial immune activation.
McElroy AK; Akondy RS; Davis CW; Ellebedy AH; Mehta AK; Kraft CS; Lyon GM; Ribner BS; Varkey J; Sidney J; Sette A; Campbell S; Ströher U; Damon I; Nichol ST; Spiropoulou CF; Ahmed R
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4719-24. PubMed ID: 25775592
[TBL] [Abstract][Full Text] [Related]
10. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
11. Ebola virus entry: a curious and complex series of events.
Moller-Tank S; Maury W
PLoS Pathog; 2015 Apr; 11(4):e1004731. PubMed ID: 25928849
[No Abstract] [Full Text] [Related]
12. In vivo Ebola virus infection leads to a strong innate response in circulating immune cells.
Caballero IS; Honko AN; Gire SK; Winnicki SM; Melé M; Gerhardinger C; Lin AE; Rinn JL; Sabeti PC; Hensley LE; Connor JH
BMC Genomics; 2016 Sep; 17(1):707. PubMed ID: 27595844
[TBL] [Abstract][Full Text] [Related]
13. The Role of Exosomal VP40 in Ebola Virus Disease.
Pleet ML; DeMarino C; Lepene B; Aman MJ; Kashanchi F
DNA Cell Biol; 2017 Apr; 36(4):243-248. PubMed ID: 28177658
[TBL] [Abstract][Full Text] [Related]
14. Ebola virus: the search for vaccines and treatments.
Wilson JA; Bosio CM; Hart MK
Cell Mol Life Sci; 2001 Nov; 58(12-13):1826-41. PubMed ID: 11766882
[TBL] [Abstract][Full Text] [Related]
15. Innate immune evasion by filoviruses.
Basler CF
Virology; 2015 May; 479-480():122-30. PubMed ID: 25843618
[TBL] [Abstract][Full Text] [Related]
16. Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody Responses.
Prescott J; Falzarano D; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S271-6. PubMed ID: 25948862
[TBL] [Abstract][Full Text] [Related]
17. Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus.
Gupta M; MacNeil A; Reed ZD; Rollin PE; Spiropoulou CF
Virology; 2012 Feb; 423(2):119-24. PubMed ID: 22197674
[TBL] [Abstract][Full Text] [Related]
18. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
[TBL] [Abstract][Full Text] [Related]
19. Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism.
Seesuay W; Jittavisutthikul S; Sae-Lim N; Sookrung N; Sakolvaree Y; Chaicumpa W
Emerg Microbes Infect; 2018 Mar; 7(1):41. PubMed ID: 29568066
[TBL] [Abstract][Full Text] [Related]
20. Persistent immune responses after Ebola virus infection.
Sobarzo A; Ochayon DE; Lutwama JJ; Balinandi S; Guttman O; Marks RS; Kuehne AI; Dye JM; Yavelsky V; Lewis EC; Lobel L
N Engl J Med; 2013 Aug; 369(5):492-3. PubMed ID: 23902512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
